Unknown

Dataset Information

0

Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells.


ABSTRACT: Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global pandemic. The prevalence/severity of COVID-19 is higher among patients with cardiovascular risk factors. Despite the expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 infection, in cardiomyocytes, there has been no conclusive evidence of direct viral infection although the presence of viral genome within COVID-19 patients' hearts has been reported. Here, we overexpressed SARS-CoV-2 genes in A549 lung epithelial cells. We then isolated extracellular vesicles (EVs) and detected the presence of viral RNA within these EVs. We observed that human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are receptive to these EVs, and viral genes were detectable in the cardiomyocytes. Accordingly, the uptake of viral RNA-harboring EVs led to an upregulation of inflammation-related genes in hiPSC-CMs. Thus, our findings indicate that SARS-CoV-2 RNA containing EVs represents an indirect route of viral RNA entry into cardiomyocytes.

SUBMITTER: Kwon Y 

PROVIDER: S-EPMC7703503 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells.

Kwon Youjeong Y   Nukala Sarath Babu SB   Srivastava Shubhi S   Miyamoto Hiroe H   Ismail Nur Izzah NI   Jousma Jordan J   Rehman Jalees J   Ong Sang-Bing SB   Lee Won Hee WH   Ong Sang-Ging SG  

Stem cell research & therapy 20201130 1


Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global pandemic. The prevalence/severity of COVID-19 is higher among patients with cardiovascular risk factors. Despite the expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 infection, in cardiomyocytes, there has been no conclusive evidence of direct viral infection although the presence of viral genome within COVID-19 patients' hearts has been report  ...[more]

Similar Datasets

| S-EPMC11910505 | biostudies-literature
2024-10-02 | E-MTAB-13966 | biostudies-arrayexpress
| S-EPMC10334823 | biostudies-literature
| S-EPMC9684507 | biostudies-literature
| S-EPMC5912190 | biostudies-literature
| S-EPMC7652393 | biostudies-literature
| S-EPMC6209632 | biostudies-literature
| S-EPMC8870779 | biostudies-literature
2024-10-03 | GSE275104 | GEO
| S-EPMC10823008 | biostudies-literature